These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7199409)

  • 1. Immediate central and peripheral haemodynamic effects of a new vasodilating agent Pinacidil (P1134) in hypertensive man.
    Carlsen JE; Kardel T; Hilden T; Tangø M; Trap-Jensen J
    Clin Physiol; 1981 Aug; 1(4):375-84. PubMed ID: 7199409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute hemodynamic effects of pinacidil and hydralazine in essential hypertension.
    Carlsen JE; Kardel T; Lund JO; McNair A; Trap-Jensen J
    Clin Pharmacol Ther; 1985 Mar; 37(3):253-9. PubMed ID: 2857601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute haemodynamic effects of pinacidil in man.
    Nicholls DP; Murtagh JG; Scott ME; Morton P; Shanks RG
    Br J Clin Pharmacol; 1986 Sep; 22(3):287-92. PubMed ID: 3768241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N''-cyano-N-4-pyridyl-N'-1,2,2-trimethylpropylguanidine, monohydrate (P 1134): a new, potent vasodilator.
    Arrigoni-Martelli E; Nielsen CK; Olsen UB; Petersen HJ
    Experientia; 1980 Apr; 36(4):445-7. PubMed ID: 7379920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic and coronary hemodynamic effects of pinacidil in awake normotensive and hypertensive dogs.
    Kawashima S; Liang CS
    Hypertension; 1985; 7(4):525-32. PubMed ID: 3891613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic characterization of pinacidil in rats. Comparison with hydralazine.
    Thoolen MJ; Van Meel JC; Wilffert B; Timmermans PB; van Zwieten PA
    Pharmacology; 1983; 27(5):245-54. PubMed ID: 6318232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of an antihypertensive vasodilator, pinacidil, on regional blood flow in conscious spontaneously hypertensive rats.
    Kimura S; Fujioka S; Fukui K; Tamaki T; Iwao H; Abe Y
    J Pharmacobiodyn; 1988 Jun; 11(6):430-7. PubMed ID: 3171884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N"-Cyano-N-4-pyridyl-N'-1,2,2-trimethyl-propylguanidine, a new vasodilating agent: acute effect of blood pressure and pharmacokinetics in hypertensive patients.
    Kardel T; Hilden T; Carlsen J; Trap-Jensen J
    J Cardiovasc Pharmacol; 1981; 3(5):1002-7. PubMed ID: 6168845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long term haemodynamic effects of pinacidil and hydralazine in arterial hypertension.
    Carlsen JE; Jensen HA; Rehling M; Lund JO; Trap-Jensen J
    Drugs; 1988; 36 Suppl 7():55-63. PubMed ID: 3076136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic and coronary hemodynamic effects of pinacidil, a new antihypertensive agent, in awake dogs: comparison with hydralazine.
    Kawashima S; Liang CS
    J Pharmacol Exp Ther; 1985 Feb; 232(2):369-75. PubMed ID: 3968638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute haemodynamic effects of carvedilol (BM 14190), a new combined beta-adrenoceptor blocker and precapillary vasodilating agent, in hypertensive patients.
    Eggertsen R; Andrén L; Sivertsson R; Hansson L
    Eur J Clin Pharmacol; 1984; 27(1):19-22. PubMed ID: 6149128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemodynamics in hypertensive patients before and during guanfacine treatment.
    Schäfer N; Rauh J; Rosenthal J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):133S-135S. PubMed ID: 6994767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Central and peripheral haemodynamic effects of prenalterol in patients with coronary heart disease.
    Svendsen TL; Carlsen JE; Hartling OJ; Trap-Jensen J
    Clin Physiol; 1981 Oct; 1(5):461-9. PubMed ID: 7199993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute hemodynamic effects of pinacidil in hypertensive patients with and without propranolol pretreatment.
    Stone CK; Wellington KL; Willick A; Sullebarger JT; Liang CS
    J Clin Pharmacol; 1991 Apr; 31(4):333-41. PubMed ID: 2037705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haemodynamic effects of guanfacine.
    Magometschnigg D; Hitzenberger G; Bonelli J
    Br J Clin Pharmacol; 1980; 10 Suppl 1(Suppl 1):125S-131S. PubMed ID: 6994766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of hypotension induced by KRN2391 and nicardipine in isoflurane anaesthetized dogs.
    Takeda S; Ozawa Y; Tomaru T
    Can J Anaesth; 1997 Sep; 44(9):1002-7. PubMed ID: 9305565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemodynamic effects of nifedipine in congestive heart failure.
    Matsumoto S; Ito T; Sada T; Takahashi M; Su KM; Ueda A; Okabe F; Sato M; Sekine I; Ito Y
    Am J Cardiol; 1980 Sep; 46(3):476-80. PubMed ID: 7415993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic and regional haemodynamic effects of vasodilators in hypertension.
    Struyker-Boudier HA; Smits JF
    Neth J Med; 1984; 27(4):146-52. PubMed ID: 6330588
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemodynamic effects of propranolol in hypertension: a review.
    Tarazi RC; Dustan HP; Bravo EL
    Postgrad Med J; 1976; 52 Suppl 4():92-100. PubMed ID: 787955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator.
    Ward JW; McBurney A; Farrow PR; Sharp P
    Eur J Clin Pharmacol; 1984; 26(5):603-8. PubMed ID: 6468476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.